No Data
No Data
Express News | Star Market Market Summary: Biopharmaceuticals and lithium battery sectors performed poorly, while semiconductor sector had mixed gains and losses.
Shouyao Holdings (688197): Outstanding independent research and development capabilities, leading the development of small molecule targeted drugs.
Coreview Pharma Group released its 2024 interim report, showing a certain degree of decrease in revenue compared to the same period last year. This is due to the fact that the sales revenue of the company's R&D products has not been realized yet, and current revenue comes from collaborative R&D income. R&D expenses are increasing along with new drug R&D projects and
Shouyao Holdings: Summary of the semi-annual report of Beijing Pharmaceutical Holdings Co., Ltd. in 2024
Shouyao Holdings: Report for the first half of 2024 of Shouyao Holdings (Peking) Co., Ltd.
Report for the first half of 2024 of Shouyao Holdings (Peking) Co., Ltd.
Summary of the semi-annual report of Beijing Pharmaceutical Holdings Co., Ltd. in 2024
No Data
No Data